Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases
Authors:
- Ruiquan LiuRLRuiquan Liu
- Wenwen DuanWDWenwen Duan
- Wenzhong YanWYWenzhong Yan
- Jinfeng ZhangJZJinfeng Zhang
- Jianjun ChengJCJianjun Cheng
- 5 January 2023
- journal article
- research article
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35 (1)
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent CancersMolecular Cancer Therapeutics, 2017
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell ResponsesCancer Immunology Research, 2015
- Polypharmacology: Challenges and Opportunities in Drug DiscoveryJournal of Medicinal Chemistry, 2014
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer ActivityCancer Research, 2010
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of CancerJournal of Medicinal Chemistry, 2010
- 2-Amino-N-pyrimidin-4-ylacetamides as A2AReceptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic SubstituentsJournal of Medicinal Chemistry, 2008
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Formal total synthesis of erythromycin A. Part III. Synthesis of Woodward's carbamate key intermediate from a 1,7-dioxaspiro[5.5]undecane derivative of erythronolide ACanadian Journal of Chemistry, 1985